Martine Zimmermann
Executive VP of Regulatory Affairs & Quality Assurance and Head of Regulatory AffairsDr. Martine Zimmermann, Pharm.D., is Independent Director of Ligand Pharmaceuticals Incorporated from September 2023. She has served as the Executive Vice President of Regulatory Affairs and Quality Assurance of Inventiva S.A. since August 2025. She serves as Independent Director at Candel Therapeutics, Inc. from September 08, 2026. She served as Director at Caelum Biosciences, Inc. since March 2019. She served as Senior VP and Head of Regulatory Affairs & Quality of Alexion Pharmaceuticals, Inc. She Senior Vice President, Head of Regulatory Affairs and R&D Quality at Ipsen Biopharmaceuticals. Throughout her career, Dr. Zimmerman has been directly involved in multiple regulatory approvals across the globe and most recently Strensiq approval in 2015 in Japan, Europe and the U.S. She has extensive expertise in regulatory affairs at both small and large pharmaceutical organizations, having worked in the United States, Europe and Asia-Pacific. Throughout her career she has been involved in all phases of drug development and in several therapeutic areas, interacting with relevant regulatory authorities in key markets, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). She has been a board member of France-based Inventiva (Euronext Paris) since 2021. Dr. Zimmerman received her Pharm.D. from University Louis Pasteur in Strasbourg (France).
Positions
- Company NameInventiva S.A.Stock CodeIVAPositionExecutive VP of Regulatory Affairs & Quality Assurance and Head of Regulatory AffairsColleagues
- AOAndrew ObenshainChief Executive Officer
- MPMark PruzanskiIndependent Chairman
- PBPierre BroquaCo-Founder
- JVJean VolatierExecutive VP Finance & Corporate Social Responsibility
- JAJason A. CampagnaPresident of Research & Development and Chief Medical Officer
- JJJean-Louis JunienChairman of Scientific Advisory Board
- HCHeinz Christoph MaeusliIndependent Director
- GAG. Andre TurenneIndependent Director
- CSCamilla SoenderbyIndependent Director
